Detection of EpCAM positive and negative circulating tumor cells in metastatic breast cancer patients

Author： Köönigsberg Robert   Obermayr Eva   Bises Giovanna   Pfeiler Georg   Gneist Margit   Wrba Fritz   de Santis Maria   Zeillinger Robert   Hudec Marcus   Dittrich Christian  

Publisher： Informa Healthcare

ISSN： 0284-186X

Source： Acta Oncologica, Vol.50, Iss.5, 2011-06, pp. : 700-710

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prognostic value of HER2-positive circulating tumor cells in patients with metastatic breast cancer

By Hayashi Naoki  

International Journal of Clinical Oncology, Vol. 17, Iss. 2, 2012-04 ,pp. : 96-104

Springer Publishing Company

Access to resources Recommend Favorite

Detection of circulating tumor cells in peripheral blood of heavily treated metastatic breast cancer patients

By Tokudome Nahomi  

Breast Cancer, Vol. 18, Iss. 3, 2011-07 ,pp. : 195-202

Springer Publishing Company

Access to resources Recommend Favorite

Detection and prognostic significance of circulating tumor cells in nonmetastatic breast cancer patients

By Hall Carolyn   Laubacher Barbara   Lucci Anthony  

Breast Cancer Management, Vol. 2, Iss. 4, 2013-07 ,pp. : 295-309

Future Medicine

Access to resources Recommend Favorite

Gemcitabine inhibits the micrometastasis of non-small cell lung cancer by targeting the EpCAM-positive circulating tumor cells via the HGF/cMET pathway

By            

International Journal of Oncology, Vol. 45, Iss. 2, 2014-01 ,pp. : 651-658

Spandidos Publications

Access to resources Recommend Favorite

Ep-CAM RNA expression predicts metastasis-free survival in three cohorts of untreated node-negative breast cancer

By Schmidt Marcus  

Breast Cancer Research and Treatment, Vol. 125, Iss. 3, 2011-02 ,pp. : 637-646

Springer Publishing Company

Access to resources Recommend Favorite